Recent

% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • CJL72 CJL72 Mar 11, 2011 5:38 PM Flag

    cNOTES:IMUC.OB

    Detailed Quote for ImmunoCellular Therapeutics Ltd. (IMUC)
    $ 2.39, -0.01, (-0.42%), Volume: 99k

    Market Cap 51.9M; ??? or + 39.321M Avg Adjusted;

    Reports provided ’07 – present;

    Per Change in Cash of +1.205M @ $2.34; Avg Shares O/S 16.8M

    Desc, Breakdown, Price: , Metric. , Weight. , Primary Weight Adj Trading Metric ,Year, Weight Adj Price.

    20.Net Income or Loss: , PT MRQ: 2.34 , (2.04) , 0.32 , (0.65), Price1, 0.75

    21.OperBalanceSHeet : , PT MRQ: 2.34 , (16) , 0.38 , (6.2), Price2, 0.90

    22. Paid In Equity: , PT MRQ: 2.34 , 2 , 0.43 , 0.74, Price3, 1.01

    23. Other Equity: , PT MRQ: 2.34 , (759) , 0.47 , (357), Price4, 1.10

    24. Other Income : , PT MRQ: 2.34 , 0 , 0.36 , 0 , LowPrice, (0.84)

    Sum Trading At: , Primary Metric(s) per CF, (774.926) , Weighted per Price Range / Change, 1.96_404 ,Primary Weight Adj Trade Metric, (362.670) , +1.42_1222_624 on adjusted level price of 92 Cents;

    Net$$M Accum Deficit Reported to Date: (19.296)
    MinRetGrowth: 0.04
    MinRetInv: 0.04
    Weighted Cost of Capital: 1.192
    Estimated Local Continuing Value in $$M: (0.00), No Value Locally;
    Estimated Factor NOT LOCAL in $$M: 1,662,480.473 or 1.65_Trillion;
    Estimated ContinuingValue:Desired Avg R&D $$M: (6.421_710.11)
    Est NOT LOCAL Price on LT Fwd Value : 1.03_5_75_404
    (0.38224), Factor Forward.
    (2.71), Price To.
    26.04% , Desired Percentage Increase in R&D from most recent report.

    Desired Market Cap Differential +11M; +.65, +170.96%;

    Currently Pricey @ +1.304; (55.726%), (21.907M) MC Per Downside;

    Do not own Shares; Follow the Co; Updated to MRQ Reports;

    Profile:
    http://finance.yahoo.com/q/pr?s=IMUC.OB+Profile


    Reference Seekingalpha.com Article:
    http://seekingalpha.com/article/255371-immunocellular-therapeutics-meets-amex-listing-requirements-poised-for-boost

    Overvalued @ +50M Market Cap; NYSE:AMEX probably will not accept it for under 50M.....and it is possible that settles at 60M Market Cap; 2.74 - 2.76 / Share if uplisted in April or May 2011;